Ken-ichi Ito
Matsumoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 155 publications
A study to learn how well the combination of encorafenib and binimetinib works and how safe it is in adults with thyroid cancer: a plain language summary.
Journal: Future oncology (London, England)
Published: March 24, 2026
Encorafenib plus binimetinib for BRAF V600-mutated thyroid cancer in Japan: final analysis.
Journal: International journal of clinical oncology
Published: March 12, 2026
Low pectoralis major muscle mass predicts the risk of post-surgical bleeding after mastectomy in patients with breast cancer.
Journal: Breast cancer research and treatment
Published: February 11, 2026
Health-related quality of life with encorafenib plus binimetinib for BRAF V600E thyroid cancer.
Journal: European thyroid journal
Published: September 24, 2025
Prognostic significance of baseline skeletal muscle index and its dynamics in patients with metastatic breast cancer undergoing eribulin treatment.
Journal: Breast cancer research and treatment
Published: May 12, 2025
Validation of the predictive ability for recurrence and the clinical utility of the 95-gene classifier (95GC) through an integrated analysis of five studies.
Journal: Breast cancer (Tokyo, Japan)
Published: March 24, 2025
Characteristics of patients with Graves' disease who developed drug resistance and required surgery.
Characteristics of patients with Graves' disease who developed drug resistance and required surgery.
Journal: Endocrine journal
Published: February 02, 2025
Activation of the AKT-mTOR pathway confers selpercatinib resistance in thyroid cancer cells harboring the CCDC6-RET fusion gene.
Journal: Biochemistry and biophysics reports
Published: January 16, 2025
Clinical implication of metastasis in the second most radioactive sentinel lymph node with nonmetastatic most radioactive node in patients with breast cancer.
Journal: Gland surgery
Published: August 19, 2024
A Phase 2 Study of Encorafenib in Combination with Binimetinib in Patients with Metastatic BRAF-Mutated Thyroid Cancer in Japan.
Journal: Thyroid : official journal of the American Thyroid Association
Published: February 12, 2024
Last Updated: 09/26/2026